Complimentary registration is available for the upcoming Science & Innovation Forum that will explore the mitigation of bacterial risk in platelets from the perspective of blood centers and transfusion services. Presented by Cerus Corporation, the program will take place at 2 p.m. ET tomorrow, April 15. Program speakers will explore safety considerations regarding pathogen reduction and testing, as well as two approaches to maintaining platelet availability, including the use of and clinical assessment of variable dose platelets. Registration to this program is complimentary but is required to attend.